Jean Noel Buy1 and Michel Ghossain2
(1)
Service Radiologie, Hopital Hotel-Dieu, Paris, France
(2)
Department of Radiology, Hotel Dieu de France, Beirut, Lebanon
4.1.1 Clinical Findings
4.1.2 Radiologic Findings
4.1.3 Biological Findings
4.2.1 US
4.2.2 MR
4.2.3 CT
4.3.1 Location of the Mass
4.3.2 Morphologic Findings
4.3.3 Vascular Findings
4.3.4 Extension
Abstract
Diagnosis of the nature of a pelvic mass is suggested on clinical, radiologic and biological findings.
4.1 Bases of Diagnosis
Diagnosis of the nature of a pelvic mass is suggested on clinical, radiologic and biological findings.
4.1.1 Clinical Findings
-
Family genetic inheritance
-
Previous treatments:
-
Medical treatment
-
Surgical and pathologic reports
-
Radiotherapy chemotherapy antioncogenic molecules
-
-
Clinical findings
-
Day of the menstrual cycle
-
Hormonal treatment
4.1.2 Radiologic Findings
-
Comparison with previous radiologic documents
-
Ultrasound, CT scan, MR, PET scan data
4.1.3 Biological Findings
-
Plasmatic tumoral markers:
-
CA125, CA19-9, and ACE, particularly in case of suspicion of ovarian surface epithelial stromal tumors
-
LDH, beta-HCG, and alpha-fetoprotein in case of suspicion of malignant germ cell tumors
-
Inhibin in case of suspicion of a granulosa tumor
-
SCC in case of suspicion of epidermoid carcinoma of the cervix, the vagina, and the vulva
-
LDH in case of suspicion of uterine leiomyosarcoma
-
In case of suspicion of ovarian metastases, CA 19-9 in case of GI tract carcinoma, CA 15-3 in case of breast carcinoma
-
These markers are not only fundamental in the diagnosis of nature of a tumor, but also in the follow-up of a woman operated from a pelvic malignant process.
-
-
Findings of an inflammatory process (CRP, white cell count number, sedimentation rate)
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

